Generative AI: While management strongly defended Its products as AI-infused and also cited NRR of 113% to 115% and ARR growth between 14% and19% as support that Generative AI was not chipping away at ...

UiPath Inc. today announced a preview of its upcoming Agent Builder tool as it outlined its vision to combine its expertise in robotic process automation with generative artificial intelligence models ...

Automation has evolved. Where a decade ago we were happy (if not positively exhilarated) to talk about the application of intelligent document processing and robotic process automation as progressive ...

UiPath Inc. (NYSE:PATH) is one of the best mid cap AI stocks to buy right now. UiPath Inc. (NYSE:PATH) is one of the best midcap AI stocks to buy right now. On August 1, 2025, UiPath announced the ...

UiPath's share price has risen in recent months despite ongoing losses and slow growth. While market conditions are stable, there is still elevated deal scrutiny and longer sales cycles, particularly ...

UiPath is dominating the robotic process automation market. Its tools can help businesses streamline their operations and cut costs. But it could face tough competition from newer generative AI ...

NEW YORK & BOCA RATON, Fla.--(BUSINESS WIRE)--UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced that it is transforming operations for Omega Healthcare, a ...

UiPath (NYSE: PATH) is back in the spotlight. The company -- one of the pioneers in robotic process automation (RPA) -- has seen renewed investor interest as artificial intelligence (AI) reshapes how ...